Last Updated on 10 August 2026

What is NAD+ | A Complete Guide

Nam Tran

Written by Nam Tran | PharmD

Experienced Pharmacist · Freelance Medical Writer, Editor & Fact-Checker

Nam Tran

Written by Nam Tran | PharmD

Experienced Pharmacist · Freelance Medical Writer, Editor & Fact-Checker

Nam Tran is an experienced pharmacist, medical writer, editor, and fact-checker with more than 14 years of combined experience in healthcare and medical communications. He has practiced across several pharmacy settings, including community pharmacy, home infusion, hospice, and specialty pharmacy, giving him a broad understanding of medication use, pharmacy operations, regulatory requirements, and patient care.

See Full Bio LinkedIn

NAD+ is a coenzyme called nicotinamide adenine dinucleotide that exists in every living cell and plays a central role in how cells produce energy and repair themselves. It is one of the most fundamental molecules in human biology, working behind the scenes in hundreds of chemical reactions. The molecule helps shuttle electrons during processes like metabolism.1

The biology of NAD+ is well-established, its levels do decline with age, and there are several methods to try to raise it. But marketing has run well ahead of the human evidence.2

This guide walks through the biology, the delivery methods, the safety record, and the regulatory picture. The goal is to help you understand the molecule before you spend money.

Medical Disclaimer: This article is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment. Always consult your healthcare provider before starting any supplement, injection, or infusion therapy. PolicyLab editorial content is medically reviewed by licensed clinicians, but individual situations vary, and the information in this article may not apply to your specific case. If you experience adverse symptoms during or after any NAD+ therapy, contact your healthcare provider or seek emergency care.

At a Glance

  • NAD+ stands for nicotinamide adenine dinucleotide.
  • It is present in every living cell and supports cellular energy production, DNA repair, sirtuin signaling, and immune function.
  • NAD+ levels decline with age and under chronic metabolic stress.
  • Oral precursors NR, NMN, and niacin have stronger human safety data than direct NAD+ supplementation.
  • Intact NAD+ does not cross cell membranes, so the body must convert precursors first.
  • Injectable and IV NAD+ are not FDA-approved finished drug products and are compounded under 503A or 503B rules.
  • NMN was reinstated as a lawful dietary supplement on September 29, 2025.
  • Talk to your healthcare provider before starting any NAD+ regimen.

How NAD+ Works in the Body

NAD+ is a coenzyme that works as an electron carrier in cellular metabolism. In its redox role, it accepts and donates electrons during glycolysis and the citric acid cycle, the chemical steps that break down food for fuel. Through this shuttle function, NAD+ supports four broad cellular jobs:3-6

  • Cellular maintenance signaling
  • DNA repair
  • Energy production
  • Immune and inflammatory signaling

Energy production is the most familiar role. NAD+ carries electrons into the electron transport chain inside mitochondria, the compartments that generate ATP, the cell’s main energy currency.7-9

Without enough NAD+, this process can slow down.10

NAD+ also fuels DNA repair. Enzymes called PARP use NAD+ to fix damaged DNA strands, which matters because unrepaired damage accumulates over time. A third job involves sirtuins, including SIRT1 and SIRT3, proteins that depend on NAD+ to regulate cellular maintenance and stress responses.11

NAD+ additionally participates in immune and inflammatory signaling.3-5

Arthur Harden and William Young first identified the molecule in 1906, and Otto Warburg described its role in metabolism in the 1930s.12

The body recycles NAD+ largely through the salvage pathway, where the enzyme NAMPT reclaims building blocks so cells do not have to make NAD+ from scratch every time.12-14

This matters because the same pathways marketed as “energy” and “anti-aging” are the ones described here, and understanding them helps judge the claims encountered.

NAD+ vs. NADH: The Redox Pair

NAD+ and NADH are two forms of the same molecule, working together as a redox pair that carries electrons through metabolism. NAD+ is the oxidized form and carries a positive charge. NADH is the reduced form, meaning it has picked up a hydride ion, a hydrogen atom with an extra electron. The two constantly convert back and forth as cells process fuel.1,3,15

What matters most is not the raw amount of NAD+ in a cell. It is the balance, the NAD+/NADH ratio. This ratio reflects how well a cell is managing its energy and repair work. A shift in that balance, rather than a single number, is what researchers watch.16,17

Keep this in mind when a product promises to “raise NAD+,” because the ratio, not the total, drives cellular function.

Why NAD+ Levels Decline With Age

NAD+ levels decline measurably as people age, and researchers have identified several primary drivers. The leading ones include rising activity of an enzyme called CD38, a slowdown in the salvage enzyme NAMPT, and accumulated cellular wear. These factors together reduce how much NAD+ cells can keep on hand.18-20

CD38 consumes NAD+, and its activity tends to increase with age. Work led by Eduardo Chini and colleagues has tied rising CD38 to falling NAD+ in aging tissue. At the same time, NAMPT recycling slows, so cells replace NAD+ less efficiently.19,21

Other contributors are more familiar. Oxidative stress, the damage caused by unstable molecules in cells, and chronic inflammation both drain NAD+. So do heavy alcohol exposure, disrupted sleep, and poor metabolic health.22-24

Marketing may claim that NAD+ drops “50 percent by middle age.” Treat that figure with caution. It reflects measurements in specific tissues and specific study populations, not a uniform, body-wide decline. The practical takeaway is that decline is real and gradual, but the exact number depends heavily on what was measured and in whom.25

Signs and Symptoms Linked to Low NAD+

Low NAD+ is not a clinical diagnosis. And there is no single blood test that doctors routinely order to measure it, nor are there any established standards to interpret it.26-28

This is important because “low NAD+” is often used loosely in marketing.

The symptoms linked to declining NAD+ overlap with many ordinary and treatable conditions, including:1

  • Fatigue and weak muscles
  • Heart failure, irregular heartbeat, and other cardiac conditions
  • Memory loss, trouble thinking, and other cognitive issues
  • Obesity, diabetes, and other metabolic conditions
  • Poor vision and other eye problems

However, each of these can arise from dozens of causes, from thyroid problems to sleep disorders to depression. Persistent symptoms warrant a proper medical workup, not a self-diagnosed NAD+ deficiency.29-31

NAD+ Benefits: What the Research Actually Shows

NAD+ research spans three evidence tiers, and this article labels each one so you can tell them apart:

  • The first tier is well-established biology from cell and animal studies.
  • The second is emerging human data from early trials.
  • The third is claims that are heavily marketed but remain unproven in humans.

Keeping these separate is the single most useful skill when evaluating NAD+ products. One caution applies: human trials so far have generally been small, short, and focused on indirect markers rather than long-term health outcomes.

Well-established in cell and animal models

In cells and in animals, evidence on NAD+ biology is plentiful. Raising NAD+ or its precursors improves mitochondrial function, supports DNA repair through PARP enzymes, and activates sirtuins in laboratory models.6,8,32,3,33

Some studies have reported improved body functions and better metabolic markers in mice, as well as extended lifespan in worms. These are animal data, not human proof. Findings in mice and worms, whose biology differs from ours, do not establish that the same effects occur in people.34,35

Emerging human data

Early human trials on boosting NAD+ are more modest. Some studies in older adults have looked at aerobic capacity, muscle function, cardiovascular markers, and cognitive support, with mixed and preliminary results.36-40

A 24-week, randomized, placebo-controlled trial examined nicotinamide riboside (NR) in 58 people with long COVID symptoms. Their cognitive test scores did not differ significantly from placebo. Although primary endpoints were non-significant, post-hoc analyses revealed that participants who took NR for at least 10 weeks reported improvements in fatigue, sleep, mood, and some executive function tasks. This does not mean NAD+ or its precursors treat long COVID. The study authors state that more research with larger trials is needed.41

Marketed but unproven in humans

The boldest claims sit here. Lifespan extension, biological-age reversal, and broad longevity benefits are marketed widely but are not established in humans. While celebrity and podcast interest has made NAD+ a cultural topic, there is not enough research demonstrating that NAD+ reverses aging in humans. No randomized human trial has demonstrated lifespan extension or biological-age reversal.2

How to Increase NAD+ Levels

There are four broad lanes for raising NAD+: lifestyle, diet, oral precursors, and clinical delivery. Each has differences in evidence, cost, and practicality. Lifestyle and diet are lower-risk and broadly beneficial regardless of NAD+. Oral precursors and clinical delivery carry more cost, and more marketing. Injections and infusions come with more regulatory and safety considerations.

Lifestyle

Exercise is a more evidence-supported lifestyle strategy tied to NAD+ metabolism, and it is well established as one of the best things you can do for long-term health regardless of its NAD+ effects.1,42-44,45-47

Stress management, mental and social engagement, limited alcohol drinking, and adequate sleep are also mentioned in this context, though the human NAD+ evidence for each may still be limited.1

Diet

Diet supplies the raw materials the body uses to make NAD+.1

Vitamin B3 sources are central here, including:

  • Fish
  • Legumes
  • Meat
  • Nuts
  • Whole grains

Tryptophan, an amino acid found in protein foods, may also support NAD+ pathways:

  • Dairy
  • Eggs
  • Poultry
  • Seeds
  • Soy

Oral precursors

Direct oral NAD+ supplements face different challenges. Firstly, the size and charge of the molecule cannot easily pass through cell membranes. Secondly, NAD+ is broken down in the stomach and intestines before it can be absorbed. That is why precursors, not direct NAD+, dominate the oral supplementation category.39,48,49

The main oral precursors are nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), niacin (NA), and nicotinamide (NAM). The body converts these into NAD+ through the salvage and Preiss-Handler pathways.50

NR carries a Generally Recognized as Safe (GRAS) notice for its brand name Niagen formulation, acknowledged by the FDA (GRN 635).51

NMN’s lawful dietary supplement status was reinstated on September 29, 2025.52

Delivery in the clinic

Clinical delivery of NAD+ includes subcutaneous injection (under the skin), intramuscular injection (into muscle), intravenous (IV) infusion (through the veins), and intranasal spray (through the nose).53-55

Since NAD+ is not available as an FDA-approved commercial product for any medical indication, these formulations are only available as compounded preparations. This means that compounded NAD+ can only be prepared under the supervision of a pharmacist or physician.54,55,56,57

The table below summarizes how the delivery routes differ in the human evidence behind them, how quickly they act, how the body must process them, and whether a prescription is required. These are general research ranges for context, not dosing recommendations, and a licensed provider should guide any actual use.

Table 1. NAD+ delivery methods compared by published human research, onset, bioavailability route, and prescription status. Entries reflect the state of human evidence and are provided for context only, not as dosing guidance.

Delivery MethodPublished Research RangeOnsetBioavailability RoutePrescription Required
Oral precursors (NMN, NR)Studied in multiple human trials over several weeks, where oral NMN and NR raised blood NAD+ levels.48,49Blood NAD+ markers rise within hours of a dose in pharmacokinetic studies.49NAD+ itself is poorly absorbed, but NMN and NR are converted to NAD+ after taking them.39,48,50No (sold as dietary supplements)
Subcutaneous and intramuscular injectionsNo published human dataNo published human dataEnters the bloodstream directly, but intact NAD+ does not cross into cells on its own; it must still be broken down and reassembled from precursors before cells can use it.39,48Yes (compounded preparation)
IV infusionLimited human data, mainly small pilot and tolerability studies rather than controlled efficacy trials.54,55Infusions typically run over several hours.54,55Enters the bloodstream directly and reaches the highest plasma levels, but intact NAD+ still cannot enter cells directly; it requires enzymatic breakdown to precursors and resynthesis at the cell surface.39,48Yes (compounded preparation)
Intranasal sprayNo published human dataNo published human dataNo published human data; intact NAD+ would still require conversion to precursors for cellular uptake.39,48Yes (compounded preparation)
Transdermal patchNo published human dataNo published human dataNo published human data; intact NAD+ would still require conversion to precursors for cellular uptake.39,48Yes (compounded preparation)

NAD+ vs. NMN vs. NR

NAD+, NMN, and NR are related but not identical. Direct NAD+ supplementation faces the bioavailability challenge described earlier, because the intact molecule does not readily enter cells.39,48,49

NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are precursors that the body converts into NAD+ (nicotinamide adenine dinucleotide).50

Between these two precursors, NR has the longer safety track record. It was identified as an NAD+ precursor by Charles Brenner in 2004.58

NR in its brand name Niagen form gained FDA-acknowledged GRAS status in 2016.51

NMN was excluded by the FDA as a dietary supplement in 2022, then reinstated as lawful on September 29, 2025.52

Both NR and NMN show stronger absorption than direct NAD+.

NAD+ Side Effects and Safety

NAD+ side effects can vary by delivery method. The safety record includes at least one serious signal: on October 21, 2025, the FDA classified a recall of a compounded NAD+ injection as Class I, its most serious category, for elevated endotoxin levels.59,60

Oral NAD+ precursors are generally well tolerated in trials, while injections and infusions carry more risk and less oversight. Below is a route-by-route summary, followed by FDA actions and caution populations.

Oral side effects

Reported oral side effects include nausea, headache, fatigue, and mild digestive discomfort. Niacin specifically can cause flushing, a warm, red, tingling sensation in the skin.61,62,63

Injection side effects

NAD+ injections can often cause soreness at the injection site and occasional bruising. Nausea, headache, fatigue, and flushing have also been reported.54,55

IV infusion side effects

Intravenous NAD+ can cause symptoms during the infusion itself, including a faster heart rate, chest tightness, and flushing. Reportedly, many IV side effects often ease when the infusion is slowed.54,55,64

FDA safety actions

The FDA has acted on injectable NAD+ safety more than once. In October 2024, the agency reminded compounders not to use food-grade NAD+ to make sterile products. The FDA noted it had received reports of severe chills, shaking, vomiting, and fatigue (reactions consistent with endotoxin exposure) following use of NAD+ injectables.65

Then, on October 21, 2025, the FDA classified a recall of a compounded NAD+ injection as Class I, its most serious level, after the product was found to have elevated endotoxin levels. These incidents are the most concrete safety signals in the category, and they demonstrate why pharmacy sourcing matters for any compounded product.59,60,66

Cancer signal and caution populations

The relationship between NAD+ precursors and cancer is one of the more uncertain areas in this field, and the animal evidence points in both directions. In one line of research, mice genetically predisposed to pancreatic cancer developed more precancerous and cancerous growths when given the precursor NMN.67

Separately, laboratory and animal work has suggested that NAD+ precursors, including NMN and NAM, may help pancreatic cancer cells survive chemotherapy by protecting them from the DNA damage that treatment relies on. Other studies, however, have found the opposite: NR slowed liver cancer growth and reduced metastasis in mouse models. So the current picture is conflicting and depends on the cancer type and model, not a settled finding in either direction.68,69

None of this has been confirmed in humans, and it should not be read as proof that supplements cause or worsen cancer in people. But the signal is notable, and the stakes high enough: anyone with a current or prior cancer diagnosis should talk with their oncology team before using any NAD+ product, and should not use one to self-treat cancer.1,54,55

Beyond cancer history, several groups should speak with a healthcare provider before starting NAD+ boosting agents, because safety data in these populations are limited:1,54,55

  • People with liver or kidney disease
  • People with unstable cardiovascular disease
  • People taking blood pressure medications
  • People taking anticoagulants (blood thinners)
  • Pregnant and nursing women
  • Children and adolescents

Is NAD+ FDA Approved and Legal?

No NAD+ injectable or IV product is FDA-approved as a finished drug. However, oral NR is established as a dietary supplement under DSHEA, the 1994 law governing supplements.54,55,51

NMN’s lawful dietary supplement status was reinstated on September 29, 2025.52

Injectable and IV NAD+ occupy a different category. They are compounded preparations, made by a 503A pharmacy (which compounds for individual patients) or a 503B outsourcing facility (which produces larger batches under stricter federal oversight). A practical example is this: compounded NAD+ is legal when prescribed by a licensed clinician working within their state scope of practice and sourced from a properly registered pharmacy. But compounded NAD+ is still not FDA-approved as a finished product.54-57,70

What to Consider Before Pursuing NAD+

Deciding whether to pursue NAD+ supplementation or therapy is personal, and the right path depends on your goals, medical history, budget, and access to a qualified provider. There is no single correct choice. The framework below can help you think through the decision without relying on marketing claims.

Your health goals and expectations

Start with what you actually want. Are you seeking energy support, faster recovery, cognitive clarity, or general healthy-aging support? Some of these goals rest on stronger evidence than others. Set expectations against the evidence. Calibrate accordingly, and be skeptical of any promise that outruns the data.

Your medical history and current medications

Your history matters as much as your goals. Active cancer or a history of cancer, pregnancy or nursing, liver or kidney disease, and use of cardiovascular medications, including blood pressure medications and anticoagulants, all warrant a careful conversation with your healthcare provider before any NAD+ regimen.1,54,55

Pharmacy compliance

Here are some things you can ask or look into when deciding on a compounding pharmacy:71-73

  • Are they a 503A state-licensed compounding pharmacy? If so, you can look up their license on the state board’s website.
    • If so, you can look up their license on the state board’s website.74
  • Or are they a 503B FDA-registered outsourcing facility?
    • If so, you can look them up on the FDA’s list of registered outsourcing facilities.75
  • Are they accredited with a professional organization like Pharmacy Compounding Accreditation Board (PCAB)?76
    • If so, you can look them up on the Accreditation Commission for Health Care (ACHC) website.77
  • Ask about their quality standards.
    • Do they only use ingredients sourced from FDA-registered manufacturers?
    • Do they use third party laboratories to test their products?

These signs do not guarantee good outcomes, but their absence can raise concerns.

How to find reputable providers

A reputable provider welcomes questions. A trustworthy clinician answers clearly and routes any unresolved medical concern back to your primary care physician.

Conclusion

NAD+ is a fundamental part of human biology. It sits at the center of cellular energy and DNA repair. Its precursor pathway has been the subject of interest. What remains unsettled is the human payoff. Evidence for meaningful longevity outcomes is still developing, and marketing has sometimes run ahead of the data.1,2,78

Pursuing NAD+ supplementation is a personal decision that depends on your goals, medical history, and budget. If you are considering it, talk with your healthcare provider first. Ask about pharmacy sourcing for any compounded preparation, and judge each claim against its evidence tier rather than its marketing.

Frequently Asked Questions

NAD+ stands for nicotinamide adenine dinucleotide. It is a coenzyme present in every living cell, where it helps carry electrons during metabolism and supports energy production, DNA repair, and other essential functions. NAD+ and NADH refer to the same molecule in different oxidation states, not different products.1

No. NMN and NR are not the same molecule as NAD+. They are precursors your body converts into NAD+. But due to its large size and polarity, NAD+ does not easily cross through cell membranes and is largely broken down in the gut. As such, more attention has fallen on precursors in the quest to boost NAD+. NMN’s lawful dietary supplement status was reinstated by the FDA on September 29, 2025.39,48-50,52

Yes. NAD+ decline is gradual across adulthood. You may see marketing materials tout a “50 percent decline by middle age” figure, but treat that cautiously. It reflects specific tissues and study populations, not a uniform, body-wide drop. The exact decline depends on what was measured and in whom.25

Because they fall under different rules. Oral NR is established as a dietary supplement under DSHEA. NMN was reinstated as a lawful supplement on September 29, 2025. Compounded injectable forms of NAD+ are not FDA-approved finished products. Instead, they are made by 503A pharmacies or 503B outsourcing facilities.51,52,54-57

Yes. Side effects and safety concerns vary by route. Oral precursors may cause nausea, headache, or flushing. IV infusions can cause increased heart rate, nausea, and flushing. On October 21, 2025, the FDA classified a compounded NAD+ injection recall as Class I for elevated endotoxin levels.61-63,54,55,64,59

Exercise has the strongest supporting evidence and benefits long-term health regardless of NAD+. Adequate sleep and good metabolic health are also associated with healthier NAD+ metabolism. Other interventions are being studied, though the human evidence is still developing.1,42-44

It can depend on the route and the outcome, and no honest answer includes a guarantee. Oral and injection onset may vary. Treat study durations as context for what was measured, not as a promise of results.

Costs might vary widely by route and provider, and prices should be confirmed directly with a licensed provider or pharmacy. Insurance rarely covers NAD+ therapy because it is not an FDA-approved treatment.54,55

References

  1. NAD (nicotinamide adenine dinucleotide). Cleveland Clinic. Updated February 26, 2026. Accessed July 15, 2026. https://my.clevelandclinic.org/health/body/nad-nicotinamide-adenine-dinucleotide
  2. Stone W. Marketers say NAD+ pills and infusions can boost longevity. What’s the evidence? NPR. May 11, 2026. Accessed July 15, 2026. https://www.npr.org/2026/05/11/nx-s1-5813664/nad-infusions-supplements-longevity-science
  3. Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119-141. doi:10.1038/s41580-020-00313-x
  4. Xie N, Zhang L, Gao W, et al. NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential. Signal Transduct Target Ther. 2020;5(1):227. doi:10.1038/s41392-020-00311-7
  5. Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab. 2018;27(3):529-547. doi:10.1016/j.cmet.2018.02.011
  6. Conlon NJ. The role of NAD+ in regenerative medicine. Plast Reconstr Surg. 2022;150(4 Suppl):41S-48S. doi:10.1097/PRS.0000000000009673
  7. Cantó C, Menzies KJ, Auwerx J. NAD+ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab. 2015;22(1):31-53. doi:10.1016/j.cmet.2015.05.023
  8. Yusri K, Jose S, Vermeulen KS, Tan TCM, Sorrentino V. The role of NAD+ metabolism and its modulation of mitochondria in aging and disease. NPJ Metab Health Dis. 2025;3(1):26. doi:10.1038/s44324-025-00067-0
  9. Dunn J, Grider MH. Physiology, adenosine triphosphate. In: StatPearls. StatPearls Publishing; 2023. Accessed July 2026. https://www.ncbi.nlm.nih.gov/books/NBK553175/
  10. Del Nagro C, Xiao Y, Rangell L, Reichelt M, O’Brien T. Depletion of the central metabolite NAD leads to oncosis-mediated cell death. J Biol Chem. 2014;289(51):35182-35192. doi:10.1074/jbc.M114.580159
  11. Amjad S, Nisar S, Bhat AA, et al. Role of NAD+ in regulating cellular and metabolic signaling pathways. Mol Metab. 2021;49:101195. doi:10.1016/j.molmet.2021.101195
  12. Hong W, Mo F, Zhang Z, Huang M, Wei X. Nicotinamide mononucleotide: a promising molecule for therapy of diverse diseases by targeting NAD+ metabolism. Front Cell Dev Biol. 2020;8:246. doi:10.3389/fcell.2020.00246
  13. Galli U, Colombo G, Travelli C, Tron GC, Genazzani AA, Grolla AA. Recent advances in NAMPT inhibitors: a novel immunotherapic strategy. Front Pharmacol. 2020;11:656. doi:10.3389/fphar.2020.00656
  14. Nishida T, Naguro I, Ichijo H. NAMPT-dependent NAD+ salvage is crucial for the decision between apoptotic and necrotic cell death under oxidative stress. Cell Death Discov. 2022;8:195. doi:10.1038/s41420-022-01007-3
  15. Energy in living systems. OpenEd CUNY. Accessed July 17, 2026. https://opened.cuny.edu/courseware/lesson/636/overview
  16. Christensen CE, Karlsson M, Winther JR, Jensen PR, Lerche MH. Non-invasive in-cell determination of free cytosolic [NAD+]/[NADH] ratios using hyperpolarized glucose show large variations in metabolic phenotypes. J Biol Chem. 2014;289(4):2344-2352. doi:10.1074/jbc.M113.498626
  17. Yang Y, Sauve AA. NAD+ metabolism: bioenergetics, signaling and manipulation for therapy. Biochim Biophys Acta. 2016;1864(12):1787-1800. doi:10.1016/j.bbapap.2016.06.014
  18. Peluso A, Damgaard MV, Mori MAS, Treebak JT. Age-dependent decline of NAD+—universal truth or confounded consensus? Nutrients. 2021;14(1):101. doi:10.3390/nu14010101
  19. Chini CCS, Peclat TR, Warner GM, et al. CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD+ and NMN levels. Nat Metab. 2020;2(11):1284-1304. doi:10.1038/s42255-020-00298-z
  20. McReynolds MR, Chellappa K, Baur JA. Age-related NAD+ decline. Exp Gerontol. 2020;134:110888. doi:10.1016/j.exger.2020.110888
  21. Camacho-Pereira J, Tarragó MG, Chini CCS, et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab. 2016;23(6):1127-1139. doi:10.1016/j.cmet.2016.05.006
  22. Poljsak B, Milisav I. NAD+ as the link between oxidative stress, inflammation, caloric restriction, exercise, DNA repair, longevity, and health span. Rejuvenation Res. 2016;19(5):406-415. doi:10.1089/rej.2015.1767
  23. Zakhari S. Overview: how is alcohol metabolized by the body? Alcohol Res Health. 2006;29(4):245-254.
  24. Escalante-Covarrubias Q, Mendoza-Viveros L, González-Suárez M, et al. Time-of-day defines NAD+ efficacy to treat diet-induced metabolic disease by synchronizing the hepatic clock in mice. Nat Commun. 2023;14(1):1685. doi:10.1038/s41467-023-37286-2
  25. Yoshino J, Imai S. Accurate measurement of nicotinamide adenine dinucleotide (NAD+) with high-performance liquid chromatography. Methods Mol Biol. 2013;1077:203-215. doi:10.1007/978-1-62703-637-5_14
  26. Balashova NV, Zavileyskiy LG, Artiukhov AV, et al. Efficient assay and marker significance of NAD+ in human blood. Front Med (Lausanne). 2022;9:886485. doi:10.3389/fmed.2022.886485
  27. Wang P, Chen M, Hou Y, et al. Fingerstick blood assay maps real-world NAD+ disparity across gender and age. Aging Cell. 2023;22(10):e13965. doi:10.1111/acel.13965
  28. Liu Y, Clement J, Grant R, Sachdev P, Braidy N. Quantitation of NAD+: why do we need to measure it? Biochim Biophys Acta Gen Subj. 2018;1862(12):2527-2532. doi:10.1016/j.bbagen.2018.07.023
  29. Thyroid disease. Cleveland Clinic. Updated March 25, 2024. Accessed July 15, 2026. https://my.clevelandclinic.org/health/diseases/8541-thyroid-disease
  30. Sleep disorders. Cleveland Clinic. Updated June 19, 2023. Accessed July 15, 2026. https://my.clevelandclinic.org/health/diseases/11429-sleep-disorders
  31. Depression. Cleveland Clinic. Updated May 28, 2026. Accessed July 13, 2026. https://my.clevelandclinic.org/health/diseases/9290-depression
  32. Wilk A, Hayat F, Cunningham R, et al. Extracellular NAD+ enhances PARP-dependent DNA repair capacity independently of CD73 activity. Sci Rep. 2020;10(1):651. doi:10.1038/s41598-020-57506-9
  33. Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014;24(8):464-471. doi:10.1016/j.tcb.2014.04.002
  34. Shade C. The science behind NMN—a stable, reliable NAD+ activator and anti-aging molecule. Integr Med (Encinitas). 2020;19(1):12-14.
  35. Mouchiroud L, Houtkooper RH, Moullan N, et al. The NAD+/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell. 2013;154(2):430-441. doi:10.1016/j.cell.2013.06.016
  36. Campelj D, Philp A. NAD+ therapeutics and skeletal muscle adaptation to exercise in humans. Sports Med. 2022;52(Suppl 1):91-99. doi:10.1007/s40279-022-01772-2
  37. Freeberg KA, Udovich CC, Martens CR, Seals DR, Craighead DH. Dietary supplementation with NAD+-boosting compounds in humans: current knowledge and future directions. J Gerontol A Biol Sci Med Sci. 2023;78(12):2435-2448. doi:10.1093/gerona/glad106
  38. Abdellatif M, Sedej S, Kroemer G. NAD+ metabolism in cardiac health, aging, and disease. Circulation. 2021;144(22):1795-1817. doi:10.1161/CIRCULATIONAHA.121.056589
  39. Vinten KT, Trętowicz MM, Coskun E, et al. NAD+ precursor supplementation in human ageing: clinical evidence and challenges. Nat Metab. 2025;7(10):1974-1990. doi:10.1038/s42255-025-01387-7
  40. Khatri S, Abdellatif M, Sedej S. Clinical evidence for the use of NAD+ precursors to slow aging. Geromedicine. 2025;1(0008):1-18. doi:10.70401/Geromedicine.2025.0008
  41. Wu CY, Reynolds WC, Abril I, et al. Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial. EClinicalMedicine. 2025;89:103633. doi:10.1016/j.eclinm.2025.103633
  42. Costford SR, Bajpeyi S, Pasarica M, et al. Skeletal muscle NAMPT is induced by exercise in humans. Am J Physiol Endocrinol Metab. 2010;298(1):E117-E126. doi:10.1152/ajpendo.00318.2009
  43. Lamb DA, Moore JH, Mesquita PHC, et al. Resistance training increases muscle NAD+ and NADH concentrations as well as NAMPT protein levels and global sirtuin activity in middle-aged, overweight, untrained individuals. Aging (Albany NY). 2020;12(10):9447-9460. doi:10.18632/aging.103218
  44. de Guia RM, Agerholm M, Nielsen TS, et al. Aerobic and resistance exercise training reverses age-dependent decline in NAD+ salvage capacity in human skeletal muscle. Physiol Rep. 2019;7(12):e14139. doi:10.14814/phy2.14139
  45. Health benefits of exercise and physical activity. National Institute on Aging. Updated January 14, 2025. Accessed July 20, 2026. https://www.nia.nih.gov/health/exercise-and-physical-activity/health-benefits-exercise-and-physical-activity
  46. Exercise and physical fitness. MedlinePlus. Updated September 15, 2025. Accessed July 20, 2026. https://medlineplus.gov/exerciseandphysicalfitness.html
  47. Benefits of physical activity. Centers for Disease Control and Prevention. Published December 4, 2025. Accessed July 20, 2026. https://www.cdc.gov/physical-activity-basics/benefits/index.html
  48. She J, Sheng R, Qin ZH. Pharmacology and potential implications of nicotinamide adenine dinucleotide precursors. Aging Dis. 2021;12(8):1879-1897. doi:10.14336/AD.2021.0523
  49. Cantó C. NAD+ precursors: a questionable redundancy. Metabolites. 2022;12(7):630. doi:10.3390/metabo12070630
  50. Alegre GFS, Pastore GM. NAD+ precursors nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR): potential dietary contribution to health. Curr Nutr Rep. 2023;12(3):445-464. doi:10.1007/s13668-023-00475-y
  51. US Food and Drug Administration. GRN No. 635: nicotinamide riboside chloride. GRAS Notices. Published August 3, 2016. Updated July 15, 2026. Accessed July 21, 2026. https://www.hfpappexternal.fda.gov/scripts/fdcc/index.cfm?set=GRASNotices&id=635
  52. US Food and Drug Administration. Docket No. FDA-2023-P-0872: Natural Products Association and Alliance for Natural Health USA—citizen petition regarding the regulatory status of β-nicotinamide mononucleotide (NMN). Regulations.gov. Updated September 29, 2025. Accessed July 21, 2026. https://www.regulations.gov/docket/FDA-2023-P-0872
  53. Head J. NAD+: recharging energy at the cellular level. Alliance for Pharmacy Compounding. Published November 20, 2025. Accessed July 22, 2026. https://a4pc.org/p3/nad-recharging-energy-at-the-cellular-level
  54. Mandal S. NAD+ injection benefits: what the research shows about energy, aging, and more. Testing.com. Updated June 30, 2026. Accessed July 22, 2026. https://www.testing.com/treatments/nad-injections-benefits/
  55. Mandal S. NAD+ injections: benefits, safety, and what to know. Testing.com. Updated June 1, 2026. Accessed July 22, 2026. https://www.testing.com/treatments/nad/
  56. US Food and Drug Administration. Human drug compounding. Updated June 15, 2026. Accessed July 22, 2026. https://www.fda.gov/drugs/guidance-compliance-regulatory-information/human-drug-compounding
  57. US Food and Drug Administration. Bulk drug substances nominated for use in compounding under section 503A of the Federal Food, Drug, and Cosmetic Act. Updated May 14, 2026. Accessed July 22, 2026. https://www.fda.gov/media/94155/download
  58. Bieganowski P, Brenner C. Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. Cell. 2004;117(4):495-502. doi:10.1016/s0092-8674(04)00416-7
  59. US Food and Drug Administration. NAD+ (nicotinamide adenine dinucleotide) for injection, 100 mg/mL and 200 mg/mL, 10 mL multi-dose amber vials, GenoGenix, LLC. Enforcement Report. Published October 21, 2025. Accessed July 23, 2026. https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=216545
  60. US Food and Drug Administration. Recalls background and definitions. Updated March 20, 2026. Accessed July 23, 2026. https://www.fda.gov/safety/industry-guidance-recalls/recalls-background-and-definitions
  61. Hwang ES, Song SB. Possible adverse effects of high-dose nicotinamide: mechanisms and safety assessment. Biomolecules. 2020;10(5):687. doi:10.3390/biom10050687
  62. Young SL, Gazzard G. The adverse effects of oral niacin/nicotinamide—an overview of reviews. Eye (Lond). 2025;39(16):2852-2859. doi:10.1038/s41433-025-04027-2
  63. Dunbar RL, Gelfand JM. Seeing red: flushing out instigators of niacin-associated skin toxicity. J Clin Invest. 2010;120(8):2651-2655. doi:10.1172/JCI44098
  64. Hawkins J, Idoine R, Kwon J, et al. Randomized, placebo-controlled, pilot clinical study evaluating acute Niagen+ IV and NAD+ IV in healthy adults. Preprint. Posted 2024. doi:10.1101/2024.06.06.24308565
  65. US Food and Drug Administration. FDA reminds compounders to use ingredients suitable for sterile compounding. Updated October 30, 2024. Accessed July 24, 2026. https://www.fda.gov/drugs/human-drug-compounding/fda-reminds-compounders-use-ingredients-suitable-sterile-compounding
  66. US Food and Drug Administration. Compounding and the FDA: questions and answers. Updated September 16, 2025. Accessed July 24, 2026. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  67. Nacarelli T, Lau L, Fukumoto T, et al. NAD+ metabolism governs the proinflammatory senescence-associated secretome. Nat Cell Biol. 2019;21(3):397-407. doi:10.1038/s41556-019-0287-4
  68. Nakazzi F, Zarei M, Lopes M, et al. Vitamin B3 derivatives support pancreatic cancer cell survival and chemotherapy resistance. Cancer Lett. 2026;645:218334. doi:10.1016/j.canlet.2026.218334
  69. Pang N, Hu Q, Zhou Y, et al. Nicotinamide adenine dinucleotide precursor suppresses hepatocellular cancer progression in mice. Nutrients. 2023;15(6):1447. doi:10.3390/nu15061447
  70. US Food and Drug Administration. FD&C Act provisions that apply to human drug compounding. Updated August 13, 2021. Accessed July 25, 2026. https://www.fda.gov/drugs/human-drug-compounding/fdc-act-provisions-apply-human-drug-compounding
  71. Levine H. Thinking of using a compounding pharmacy? What you need to know. Harvard Health Publishing. September 26, 2024. Accessed July 13, 2026. https://www.health.harvard.edu/healthy-aging-and-longevity/thinking-of-using-a-compounding-pharmacy-what-you-need-to-know
  72. Bieber AM. Compounding pharmacies: the real story. Cedars-Sinai. Published May 22, 2025. Accessed July 13, 2026. https://www.cedars-sinai.org/stories-and-insights/healthy-living/compounding-pharmacies-the-real-story
  73. Alliance for Pharmacy Compounding. Find a compounding pharmacy. Accessed July 13, 2026. https://a4pc.org/find-a-compounder
  74. National Association of Boards of Pharmacy. Boards of pharmacy. Accessed July 13, 2026. https://nabp.pharmacy/about/boards-of-pharmacy/
  75. US Food and Drug Administration. Registered outsourcing facilities. Updated July 13, 2026. Accessed July 13, 2026. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
  76. Accreditation Commission for Health Care. PCAB accreditation for modern compounding pharmacies. Accessed July 13, 2026. https://achc.org/pcab-compounding-pharmacy/
  77. Accreditation Commission for Health Care. Search for ACHC-accredited organizations. Accessed July 13, 2026. https://organization.achc.org/
  78. Hill J. NAD+ supplements: can they really slow down aging? Cleveland Clinic Health Essentials. Published February 26, 2026. Accessed July 25, 2026. https://health.clevelandclinic.org/nad-supplement